药品注册申请号:020258
申请类型:NDA (新药申请)
申请人:HARROW EYE
申请人全名:HARROW EYE LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 IOPIDINE APRACLONIDINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 0.5% BASE Yes Yes AT 1993/07/30 1993/07/30 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
1993/07/30 ORIG-1(原始申请) Approval Type 3 - New Dosage Form PRIORITY
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/03/01 SUPPL-30(补充) Approval Labeling-Package Insert STANDARD
2017/04/06 SUPPL-26(补充) Approval Labeling-Package Insert STANDARD
2003/05/09 SUPPL-19(补充) Approval Labeling STANDARD
2002/12/04 SUPPL-18(补充) Approval Manufacturing (CMC)-Control PRIORITY
2002/03/13 SUPPL-17(补充) Approval Manufacturing (CMC)-Control PRIORITY
2001/09/21 SUPPL-16(补充) Approval Manufacturing (CMC)-Control PRIORITY
2001/03/16 SUPPL-15(补充) Approval Manufacturing (CMC)-Control PRIORITY
2000/09/13 SUPPL-14(补充) Approval Manufacturing (CMC)-Control PRIORITY
2000/05/16 SUPPL-11(补充) Approval Labeling STANDARD
2000/02/18 SUPPL-13(补充) Approval Manufacturing (CMC) PRIORITY
1999/09/28 SUPPL-10(补充) Approval Manufacturing (CMC)-Control PRIORITY
1999/08/17 SUPPL-12(补充) Approval Manufacturing (CMC)-Control PRIORITY
1999/04/07 SUPPL-9(补充) Approval Manufacturing (CMC) PRIORITY
1999/03/11 SUPPL-7(补充) Approval Manufacturing (CMC)-Control PRIORITY
1999/02/05 SUPPL-8(补充) Approval Manufacturing (CMC) PRIORITY
1998/08/04 SUPPL-6(补充) Approval Manufacturing (CMC)-Control PRIORITY
1998/01/15 SUPPL-5(补充) Approval Manufacturing (CMC) PRIORITY
1997/04/09 SUPPL-4(补充) Approval Manufacturing (CMC)-Packaging PRIORITY
1996/12/17 SUPPL-3(补充) Approval Manufacturing (CMC) PRIORITY
1995/11/01 SUPPL-2(补充) Approval Manufacturing (CMC)-Control PRIORITY
1995/11/01 SUPPL-1(补充) Approval Manufacturing (CMC)-Control PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:APRACLONIDINE HYDROCHLORIDE; 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC; 规格:EQ 0.5% BASE; 治疗等效代码:AT<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020258 001 NDA IOPIDINE APRACLONIDINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 0.5% BASE Prescription Yes Yes AT 1993/07/30 HARROW EYE
077764 001 ANDA APRACLONIDINE HYDROCHLORIDE APRACLONIDINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 0.5% BASE Prescription No No AT 2009/03/12 RISING
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database